Table of Contents
Volume 2013, Article ID 681475, 8 pages
Clinical Study

HDL-C Response Variability to Niacin ER in US Adults

1GlaxoSmithKline, Clinical Effectiveness & Safety, 5 Moore Drive, B.3116, Durham, NC 27709-3398, USA
2GlaxoSmithKline, Heart Failure DPU, Medicines Discovery and Development, King of Prussia, PA 19406, USA
3GlaxoSmithKline, Worldwide Epidemiology, Durham, NC 27709, USA
4Exponent Health Sciences, Bellevue, WA 98004, USA

Received 20 December 2012; Accepted 28 January 2013

Academic Editor: Francisco Blanco-Vaca

Copyright © 2013 Jennifer B. Christian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jennifer B. Christian, Eric J. Olson, Jeffery K. Allen, and Kimberly A. Lowe, “HDL-C Response Variability to Niacin ER in US Adults,” Cholesterol, vol. 2013, Article ID 681475, 8 pages, 2013.